Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference160 articles.
1. Regulation of surface and intracellular expression of CTLA4 on mouse T cells;Alegre;J Immunol,1996
2. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement;Linsley;Immunity,1996
3. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases;Chuang;J Immunol,1999
4. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4;Cinek;J Immunol,2000
5. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression;Carreno;J Immunol,2000
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis;Frontiers in Immunology;2024-01-17
2. Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study;ESMO Open;2023-12
3. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy;European Journal of Medicinal Chemistry;2023-11
4. The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial;Nature Medicine;2023-10-19
5. The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review;Diagnostics;2023-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3